1. Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies
   Yang Shi et al, 2022, Frontiers in Oncology CrossRef
2. Targeting Epigenetic Aberrations in Esophageal Squamous Cell Carcinoma
   Feng Li et al, 2020, Current Pharmacology Reports CrossRef
3. Evaluation of Cytotoxic Activity of Epigenetic Drugs in Oesophageal Squamous Cell Carcinoma
   Róisín M. Cassidy et al, 2023, European Journal of Medical and Health Sciences CrossRef
4. Refocusing the Use of Psychiatric Drugs for Treatment of Gastrointestinal Cancers
   Mariana Avendaño-Félix et al, 2020, Frontiers in Oncology CrossRef
5. Combined therapy of colon carcinomas with an oncolytic adenovirus and valproic acid
   Christian Bressy et al, 2017, Oncotarget CrossRef
6. NFkB hyperactivation causes invasion of esophageal squamous cell carcinoma with EGFR overexpression and p120-catenin down-regulation
   Heather L. Lehman et al, 2018, Oncotarget CrossRef
7. Ability of plasma-activated acetated Ringer’s solution to induce A549 cell injury is enhanced by a pre-treatment with histone deacetylase inhibitors
   Tetsuo Adachi et al, 2020, Journal of Clinical Biochemistry and Nutrition CrossRef
8. Targeting DNA Double-Strand Break (DSB) Repair to Counteract Tumor Radio-resistance
   Yucui Zhao et al, 2019, Current Drug Targets CrossRef
9. The Valproate Mediates Radio-Bidirectional Regulation Through RFWD3-Dependent Ubiquitination on Rad51
   Guochao Liu et al, 2021, Frontiers in Oncology CrossRef